Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the <scp>FDA</scp> Adverse Event Reporting System

Tao Chen, Kexin Shu, Hongyi Xiao, Yonghua Yuan, Fujun Zhang, Yu Liu

Open source

DOI
10.1002/cam4.72206
Published
2026-08-26
Container
Cancer Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72206,
  title = {Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the
                    <scp>FDA</scp>
                    Adverse Event Reporting System},
  author = {Tao Chen and Kexin Shu and Hongyi Xiao and Yonghua Yuan and Fujun Zhang and Yu Liu},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.72206},
  url = {https://doi.org/10.1002/cam4.72206}
}

RIS

TY  - JOUR
TI  - Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the
                    <scp>FDA</scp>
                    Adverse Event Reporting System
AU  - Tao Chen
AU  - Kexin Shu
AU  - Hongyi Xiao
AU  - Yonghua Yuan
AU  - Fujun Zhang
AU  - Yu Liu
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.72206
UR  - https://doi.org/10.1002/cam4.72206
ER  - 

APA

Chen, T., Shu, K., Xiao, H., Yuan, Y., Zhang, F., & Liu, Y. (2026). Neurological Adverse Events Associated With Immune Checkpoint Inhibitors Identified Through Disproportionality Analysis of the <scp>FDA</scp> Adverse Event Reporting System. Cancer Medicine. https://doi.org/10.1002/cam4.72206

Source records